Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.34 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28912213 | 0.85 | ALDH1A1 (0.33) | SMN1; SMN2ALDH1A1 | |
| SCHEMBL28990219 | 0.82 | TDP1 (0.38) | SMN1; SMN2CA1CA2ACHEALDH1A1 | |
| SCHEMBL28371880 | 0.80 | SMN1; SMN2 (0.37) | SMN1; SMN2CA1CA2ACHECA14 | |
| SCHEMBL8651385 | 0.78 | HTT (0.33) | HTT | |
| SCHEMBL12963060 | 0.77 | CA1 (0.35) | SMN1; SMN2CA1CA2ACHECA14 | |
| SCHEMBL3140450 | 0.76 | SMN1; SMN2 (0.42) | SMN1; SMN2CA1CA2ACHECA14 | |
| SCHEMBL2260945 | 0.76 | HTT (0.32) | HTT | |
| SCHEMBL1241162 | 0.76 | SMN1; SMN2 (0.42) | SMN1; SMN2CA1CA2ACHECA14 | |
| SCHEMBL25288847 | 0.75 | ALDH1A1 (0.41) | ALDH1A1 | |
| SCHEMBL3868205 | 0.75 | ALDH1A1 (0.42) | KMT2AALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 413 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026102880-A1 | FULL-TEMPERATURE-RANGE POLYMER-BASED SOLID ELECTROLYTE, SOLID-STATE BATTERY AND PREPARATION METHOD | 固态离子能源科技(武汉)有限公司 | 2026-05-21 | — | — | WO | claimed |
| CN-119490607-A | Full-temperature-range polymer-based solid electrolyte, solid battery and preparation method | 固态离子能源科技(武汉)有限公司 | 2025-02-21 | — | — | CN | claimed |
| US-7598413-B2 | Process for producing fluorine-containing alkylsulfonylaminoethyl α-substituted acrylate | CENTRAL GLASS COMPANY, LIMITED (JP) | 2009-10-06 | — | — | US | claimed |
| CN-100489520-C | Analysis and determination method of tetrafluoro-propionic methyle ester methoxide | DONGYUE SHENZHOU NEW MAT CO (CN) | 2009-05-20 | — | — | CN | claimed |
| US-20090069595-A1 | Process for Producing Fluorine-Containing Alkylsulfonylaminoethyl Alpha-Substituted Acrylate | CENTRAL GLASS COMPANY, LIMITED (JP) | 2009-03-12 | — | — | US | claimed |
| CN-101000328-A | Analytical investigating method of tetrafluoro-propionic methyle ester methoxide | DONGYUE SHENZHOU NEW MAT CO (CN) | 2007-07-18 | — | — | CN | claimed |
| CN-1539827-A | 6-substitution-5-fluorin-4-hydroxy miazines compound and intermediate, synthetic method and usage | 中国科学院上海有机化学研究所 | 2004-10-27 | — | — | CN | claimed |
| CN-1455663-A | Novel aerosol formulation containing polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-11-12 | — | — | CN | claimed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| CN-1083466-A | Synthesizing of desflurant | ANAQUEST INC (US) | 1994-03-09 | — | — | CN | claimed |
| JP-63211245-A | — | — | None | — | — | JP | disclosed |
| JP-63303950-A | — | — | None | — | — | JP | disclosed |
| WO-2026102880-A1 | FULL-TEMPERATURE-RANGE POLYMER-BASED SOLID ELECTROLYTE, SOLID-STATE BATTERY AND PREPARATION METHOD | 固态离子能源科技(武汉)有限公司 | 2026-05-21 | — | — | WO | disclosed |
| US-12620622-B2 | Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same | DAIKIN INDUSTRIES, LTD. (JP) | 2026-05-05 | — | — | US | disclosed |
| CN-1083466-A | Synthesizing of desflurant | ANAQUEST INC (US) | 1994-03-09 | — | — | CN | disclosed |
| EP-0468681-A1 | Alfa-fluorocarboxylic acid derivatives as intermediates for the preparation of fungicides | ZENECA LIMITED (GB) | 1992-01-29 | — | — | EP | disclosed |
| JP-S63303950-A | FLUORINE-CONTAINING COMPOUND AND PRODUCTION THEREOF | DAIKIN IND LTD | 1988-12-12 | — | — | JP | disclosed |
| JP-S63211245-A | PRODUCTION OF 2,3,3,3-TETRAFLUOROPROPENE | DAIKIN IND LTD | 1988-09-02 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12620622-B2 | Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same | ASH2L, OLA1, ODC1 | SMN1; SMN2 1758/4885CA1 167/4885CA2 32/4885 |
| US-20090069595-A1 | Process for Producing Fluorine-Containing Alkylsulfonylaminoethyl Alpha-Substituted Acrylate | AFF1, AFF2, AFF4 | SMN1; SMN2 1130/4885CA1 2527/4885CA2 2022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.